David Shapiro Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Shapiro.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Shapiro. David Shapiro is CMO and EVP - Development in INTERCEPT PHARMACEUTICALS INC ($ICPT).
David Shapiro in INTERCEPT PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Shapiro: CMO and EVP - Development
Holdings: 18,796 shares
Current Value: $2,134,662
Latest Transaction: Feb 19 2015
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David Shapiro in INTERCEPT PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 5,294 | 45,882 | 35,425 | |
| Feb 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 3,500 | 36,400 | 3,703 | |
| Feb 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 212.12 | 2,000 | 424,242 | 18,796 | 20.8 K to 18.8 K (-9.62 %) |
| Feb 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 210.95 | 1,146 | 241,749 | 20,796 | 21.9 K to 20.8 K (-5.22 %) |
| Feb 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 204.62 | 1,500 | 306,930 | 21,942 | 23.4 K to 21.9 K (-6.40 %) |
| Feb 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 3,500 | 36,400 | 23,442 | 19.9 K to 23.4 K (+17.55 %) |
| Feb 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 5,294 | 45,882 | 19,942 | 14.6 K to 19.9 K (+36.14 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 3,500 | 36,400 | 7,203 | |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 4,000 | 34,667 | 10,971 | |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 208.10 | 953 | 198,317 | 14,648 | 15.6 K to 14.6 K (-6.11 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 207.01 | 2,379 | 492,466 | 15,601 | 18 K to 15.6 K (-13.23 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 206.03 | 1,068 | 220,041 | 17,980 | 19 K to 18 K (-5.61 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 204.20 | 3,100 | 633,009 | 19,048 | 22.1 K to 19 K (-14.00 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 3,500 | 36,400 | 22,148 | 18.6 K to 22.1 K (+18.77 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 4,000 | 34,667 | 18,648 | 14.6 K to 18.6 K (+27.31 %) |
| Jan 07 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 172.63 | 664 | 114,627 | 14,648 | 15.3 K to 14.6 K (-4.34 %) |
| Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 0.00 | 1,623 | 0 | 6,490 | |
| Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 158.71 | 376 | 59,675 | 15,312 | 15.7 K to 15.3 K (-2.40 %) |
| Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 0.00 | 1,623 | 0 | 15,688 | 14.1 K to 15.7 K (+11.54 %) |
| Nov 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,000 | 41,600 | 10,703 | |
| Nov 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 160.30 | 502 | 80,471 | 14,065 | 14.6 K to 14.1 K (-3.45 %) |
| Nov 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 159.62 | 1,698 | 271,038 | 14,567 | 16.3 K to 14.6 K (-10.44 %) |
| Nov 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 158.45 | 1,590 | 251,939 | 16,265 | 17.9 K to 16.3 K (-8.91 %) |
| Nov 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 157.28 | 1,000 | 157,283 | 17,855 | 18.9 K to 17.9 K (-5.30 %) |
| Nov 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,000 | 41,600 | 18,855 | 14.9 K to 18.9 K (+26.93 %) |
| Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,000 | 41,600 | 14,703 | |
| Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 0.00 | 1,622 | 0 | 8,113 | |
| Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 233.97 | 832 | 194,664 | 14,855 | 15.7 K to 14.9 K (-5.30 %) |
| Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 234.01 | 500 | 117,005 | 15,687 | 16.2 K to 15.7 K (-3.09 %) |
| Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 232.97 | 1,000 | 232,965 | 16,187 | 17.2 K to 16.2 K (-5.82 %) |
| Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 232.24 | 1,500 | 348,358 | 17,187 | 18.7 K to 17.2 K (-8.03 %) |
| Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 227.69 | 688 | 156,651 | 18,687 | 19.4 K to 18.7 K (-3.55 %) |
| Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 226.30 | 500 | 113,151 | 19,375 | 19.9 K to 19.4 K (-2.52 %) |
| Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,000 | 41,600 | 19,875 | 15.9 K to 19.9 K (+25.20 %) |
| Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 0.00 | 1,622 | 0 | 15,875 | 14.3 K to 15.9 K (+11.38 %) |
| Aug 29 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 10,000 | 86,667 | 30,131 | |
| Aug 29 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 296.14 | 700 | 207,295 | 14,253 | 15 K to 14.3 K (-4.68 %) |
| Aug 29 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 295.61 | 1,200 | 354,732 | 14,953 | 16.2 K to 15 K (-7.43 %) |
| Aug 29 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 293.89 | 4,250 | 1,249,025 | 16,153 | 20.4 K to 16.2 K (-20.83 %) |
| Aug 29 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 293.05 | 3,850 | 1,128,233 | 20,403 | 24.3 K to 20.4 K (-15.87 %) |
| Aug 29 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 10,000 | 86,667 | 24,253 | 14.3 K to 24.3 K (+70.16 %) |
| Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,000 | 41,600 | 22,703 | |
| Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 292.16 | 4,000 | 1,168,656 | 14,253 | 18.3 K to 14.3 K (-21.91 %) |
| Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 288.00 | 774 | 222,912 | 18,253 | 19 K to 18.3 K (-4.07 %) |
| Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,000 | 41,600 | 19,027 | 15 K to 19 K (+26.62 %) |
| May 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,000 | 41,600 | 34,703 | |
| May 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 278.10 | 1,000 | 278,104 | 14,440 | 15.4 K to 14.4 K (-6.48 %) |
| May 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 277.00 | 2,000 | 554,000 | 15,440 | 17.4 K to 15.4 K (-11.47 %) |
| May 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 275.00 | 1,000 | 275,000 | 17,440 | 18.4 K to 17.4 K (-5.42 %) |
| May 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 272.00 | 743 | 202,096 | 18,440 | 19.2 K to 18.4 K (-3.87 %) |
| May 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,000 | 41,600 | 19,183 | 15.2 K to 19.2 K (+26.35 %) |
| Apr 15 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | A | 266.01 | 8,255 | 2,195,913 | 8,255 | |
| Apr 15 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | A | 266.01 | 1,835 | 488,128 | 1,835 | |
| Apr 15 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Grant | A | 0.00 | 1,504 | 0 | 15,183 | 13.7 K to 15.2 K (+10.99 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,326 | 44,991 | 0 | |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 0.00 | 1,622 | 0 | 11,358 | |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 321.95 | 879 | 282,997 | 13,679 | 14.6 K to 13.7 K (-6.04 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 338.16 | 500 | 169,082 | 14,558 | 15.1 K to 14.6 K (-3.32 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 335.84 | 1,000 | 335,844 | 15,058 | 16.1 K to 15.1 K (-6.23 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 334.52 | 388 | 129,793 | 16,058 | 16.4 K to 16.1 K (-2.36 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 333.22 | 1,626 | 541,809 | 16,446 | 18.1 K to 16.4 K (-9.00 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 330.06 | 1,000 | 330,060 | 18,072 | 19.1 K to 18.1 K (-5.24 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,326 | 44,991 | 19,072 | 14.7 K to 19.1 K (+29.34 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 0.00 | 1,622 | 0 | 14,746 | 13.1 K to 14.7 K (+12.36 %) |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,000 | 41,600 | 38,703 | |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,917 | 51,137 | 42,703 | |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 463.91 | 1,000 | 463,910 | 13,124 | 14.1 K to 13.1 K (-7.08 %) |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 444.25 | 1,000 | 444,246 | 14,124 | 15.1 K to 14.1 K (-6.61 %) |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 432.30 | 1,000 | 432,303 | 15,124 | 16.1 K to 15.1 K (-6.20 %) |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 422.05 | 258 | 108,888 | 16,124 | 16.4 K to 16.1 K (-1.57 %) |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 421.46 | 742 | 312,724 | 16,382 | 17.1 K to 16.4 K (-4.33 %) |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 410.92 | 456 | 187,379 | 17,124 | 17.6 K to 17.1 K (-2.59 %) |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,000 | 41,600 | 17,580 | 13.6 K to 17.6 K (+29.46 %) |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,917 | 51,137 | 13,580 | 8.7 K to 13.6 K (+56.76 %) |
Page: 1